SACRAMENTO, Calif. - The number of inmates being observed for possible infection with Legionnaires' disease at San Quentin State Prison near San Francisco has jumped from 71 to 85, but the number of confirmed diagnoses held steady at six, authorities said Tuesday.
LONDON - Medical researchers called on Wednesday for detailed, thoughtful debate on future use of new genetic technology that has the potential to create "designer babies".
(Reuters Health) - More minority patients have been getting kidney transplants since 2003, when medical criteria for allocating transplantable kidneys from deceased donors were loosened, according to a new study.
SACRAMENTO, Calif. - A controversial bill to allow physician-assisted suicide for terminally ill patients in California passed a key legislative committee on Tuesday, after failing in the legislature earlier this summer amid opposition from the Catholic Church.
- Amgen Inc said its experimental bone drug was found to be more effective than an already marketed drug in a late-stage study.
LONDON - Novartis and Amgen are joining forces in the hunt for an Alzheimer's treatment, in the latest sign that drugmakers believe an effective therapy for the memory-robbing disease may be within reach.
- The Food and Drug Administration on Tuesday issued warning letters to five distributors of pure powdered caffeine, as the federal agency stepped up efforts to curtail ingestion of the stimulant in its pure form.
NEW YORK - Ten weeks after closing its $8.4 billion purchase of Synageva BioPharma Corp, Alexion Pharmaceuticals Inc on Tuesday announced European approval for the key drug acquired through the deal, an enzyme-replacement therapy for an ultra-rare, life threatening disease.
Boston, Massachusetts - In a laboratory at Boston Children's Hospital a cure for genetic deafness is taking shape. Lead researcher Jeff Holt says that if all goes as planned, children of the future who lose their ability to hear due to genetic mutation will never go deaf. | Video